Operating, investing and financing flows differ from the reported change in cash by 52000000, beyond tolerance 18180000.00.
DXC Technology Co (DXC) reported revenue of $12.64B and net income of $18.00M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from DXC Technology Co’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Processing & Data Preparation.
Income
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.64B | $12.87B | $13.67B | $14.43B | $16.26B | $17.73B | $19.58B | $20.75B | $21.73B | $7.61B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $970.00M | $1.02B | $1.01B | $1.14B | $1.38B | $1.10B | $2.06B | $3.27B | $2.99B | $618.00M |
| Net income | $18.00M | $389.00M | $91.00M | -$568.00M | $718.00M | -$149.00M | -$5.37B | $1.26B | $1.75B | -$123.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 178.65M | shares 184.92M | shares 198.78M | shares 228.99M | shares 255.21M | shares 254.14M | shares 258.57M | shares 281.43M | shares 289.77M | shares 140.39M |
| Pretax income | $318.00M | $630.00M | $109.00M | -$885.00M | $1.14B | $654.00M | -$5.23B | $1.52B | $1.30B | -$174.00M |
| Income tax expense | $290.00M | $234.00M | $23.00M | -$319.00M | $405.00M | $800.00M | $130.00M | $288.00M | -$242.00M | -$74.00M |
| Diluted EPS | $0.10 | $2.10 | $0.46 | $-2.48 | $2.81 | $-0.59 | $-20.76 | $4.47 | $6.04 | $-0.88 |
| Selling, general & administrative | $1.40B | $1.35B | $1.24B | $1.38B | $1.41B | $2.07B | $2.05B | $1.96B | $1.89B | $1.28B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.74B | $1.80B | $1.22B | $1.86B | $2.67B | $2.97B | $3.68B | $2.90B | $2.59B | $1.26B |
| Total assets | $12.89B | $13.20B | $13.87B | $15.84B | $20.14B | $22.04B | $26.01B | $29.57B | $33.92B | $8.66B |
| Current assets | $5.36B | $5.36B | $5.14B | $6.12B | $7.45B | $8.21B | $8.99B | $9.07B | $9.62B | $3.25B |
| Total liabilities | $9.68B | $9.72B | $10.80B | $12.02B | $14.76B | $16.73B | $20.88B | $17.85B | $20.08B | $6.50B |
| Current liabilities | $3.94B | $4.41B | $4.39B | $5.19B | $6.85B | $8.15B | $7.90B | $9.45B | $9.85B | $2.95B |
| Total equity incl. NCI | $3.21B | $3.49B | $3.07B | $3.82B | $5.38B | $5.31B | $5.13B | $11.72B | $13.84B | $2.17B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $2.97B | $2.97B | $3.25B | $3.44B | $3.85B | $4.16B | $4.39B | $5.18B | $5.48B | $1.64B |
| Goodwill | $527.00M | $526.00M | $532.00M | $539.00M | $617.00M | $641.00M | $2.02B | $7.61B | $7.62B | $1.86B |
| Long-term debt | $3.03B | $3.00B | $3.82B | $3.90B | $4.06B | $4.34B | $8.67B | $5.47B | $6.09B | $2.22B |
| Accounts payable | $561.00M | $549.00M | $846.00M | $782.00M | $840.00M | $914.00M | $1.60B | $1.67B | $1.51B | $410.00M |
Cash flow
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.25B | $1.40B | $1.36B | $1.42B | $1.50B | $124.00M | $2.35B | $1.78B | $2.57B | $619.00M |
| Capital expenditures | $212.00M | $248.00M | $182.00M | $267.00M | $254.00M | $261.00M | $350.00M | $297.00M | $224.00M | $246.00M |
| Investing cash flow | -$484.00M | -$512.00M | -$491.00M | -$635.00M | -$60.00M | $4.66B | -$2.14B | $69.00M | $719.00M | -$565.00M |
| Financing cash flow | -$776.00M | -$317.00M | -$1.49B | -$1.51B | -$1.82B | -$5.48B | $657.00M | -$1.66B | -$1.89B | $93.00M |
| Net change in cash | Unavailable | $572.00M | -$634.00M | -$814.00M | -$296.00M | -$711.00M | $780.00M | $170.00M | $1.46B | $87.00M |
| Stock-based compensation | $86.00M | $79.00M | $109.00M | $108.00M | $101.00M | $56.00M | $68.00M | $74.00M | $93.00M | $75.00M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | $0 | $0 | $53.00M | $214.00M | $210.00M | $174.00M | $78.00M |
| Common share repurchases | $249.00M | $14.00M | $898.00M | $669.00M | $628.00M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $1.18B | $1.31B | $1.43B | $1.55B | $1.74B | $1.99B | $1.96B | $2.02B | $2.01B | $658.00M |
Derived
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.04B | $1.15B | $1.18B | $1.15B | $1.25B | -$137.00M | $2.00B | $1.49B | $2.34B | $373.00M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 7.7% | 7.9% | 7.4% | 7.9% | 8.5% | 6.2% | 10.5% | 15.8% | 13.8% | 8.1% |
| FCF margin | 8.2% | 8.9% | 8.6% | 8.0% | 7.7% | -0.8% | 10.2% | 7.2% | 10.8% | 4.9% |
| SBC / revenue | 0.7% | 0.6% | 0.8% | 0.7% | 0.6% | 0.3% | 0.3% | 0.4% | 0.4% | 1.0% |
| Current ratio | 1.36x | 1.22x | 1.17x | 1.18x | 1.09x | 1.01x | 1.14x | 0.96x | 0.98x | 1.10x |
| Revenue YoY growth | -1.8% | -5.8% | -5.3% | -11.3% | -8.3% | -9.4% | -5.7% | -4.5% | 185.7% | Unavailable |
| Net margin | 0.1% | 3.0% | 0.7% | -3.9% | 4.4% | -0.8% | -27.4% | 6.1% | 8.1% | -1.6% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 1.7% | 1.9% | 1.3% | 1.9% | 1.6% | 1.5% | 1.8% | 1.4% | 1.0% | 3.2% |
| Long-term debt / equity | 0.94x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 91.2% | 37.1% | 21.1% | Unavailable | 35.5% | 122.3% | Unavailable | 19.0% | -18.6% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DXC in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Operating, investing and financing flows differ from the reported change in cash by 63000000, beyond tolerance 54760000.00.